Clinical Trials Directory

Trials / Completed

CompletedNCT06369740

Case and Use Scenario Study to Gain Knowledge on the User Needs for a Medical Device for Hemophilia a Monitoring

Status
Completed
Phase
Study type
Observational
Enrollment
74 (actual)
Sponsor
Enzyre B.V. · Industry
Sex
All
Age
12 Years
Healthy volunteers
Not accepted

Summary

This observational study consists of two parts. In part one, case scenario focus groups with hemophilia A patients and healthcare providers (HCPs) will be held. This parts aims to identify potential use scenarios of a point of care (POC) in vitro medical for patients with hemophilia A. The main questions it aims to answer are: * How is coagulation lab testing for patients with hemophilia A currently organized? * What is the interest and what are desired alternatives of a POC in-vitro diagnostic medical device for patients with hemophilia A? Part two of the study consists of a use scenario study in which patients with hemophilia A and HCPs will evaluate two types of non-functional mock-ups of a POC in vitro medical device. The main goal of this part is to evaluate the usability of the current prototypes of the POC device.

Conditions

Interventions

TypeNameDescription
OTHERCase scenarios - questionnaireParticipants fill in a questionnaire on the current care of hemophilia A and envisioned use scenarios of a point-of-care diagnostic device for hemophilia A.
OTHERCase scenarios - Focus groupsParticipants partake in focus groups on the current care for hemophilia A, the envisioned use scenarios of point-of-care diagnostic device for hemophilia A and desired features of such a diagnostic device.
OTHERUse scenarios - Usability testParticipants are asked to perform basic tasks with the mock-ups with minimal instructions, they will also be given a graphic of the user interface (GUI).
OTHERUse scenarios - interviewThe participants will be interviewed and asked for their opinions and experiences with the mock-ups.

Timeline

Start date
2024-08-22
Primary completion
2024-08-25
Completion
2024-08-25
First posted
2024-04-17
Last updated
2024-10-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06369740. Inclusion in this directory is not an endorsement.